1-13 of 13
Ruimin Hong
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ultra-low-dose IL-10-expressing CAR-T cells achieve high efficacy in R/R DLBCL: An update analysis

Free
Yongxian Hu, Mingming Zhang, Min Gao, Yetian Dong, Shan Fu, Jingjing Feng, Ruimin Hong, Guoqing Wei, Duoduo Zhao, Jiazhen Cui, Simao Huang, Tingting Yang, Yilin Li, Xunuo Zhu, Daojun Bai, Jingjing Ren, Chongling Liu, Youjia Li, Qian Chen, Zhan Zhou, Dongrui Wang, Yugang Guo, Li Tang, Xingbing Wang, He Huang
Journal: Blood
Blood (2025) 146 (Supplement 1): 2395.
https://doi.org/10.1182/blood-2025-2395
Published: 2025
Journal Articles

Rituximab, lenalidomide, and zanubrutinib (ZR2) with sequential CAR-T cell as first-line therapy for high-risk large B cell lymphoma

Free
Mingming Zhang, Lianxuan Liu, Yongxian Hu, Guoqing Wei, Shan Fu, Jingjing Feng, Ruimin Hong, Alex H. Zhang, He Huang
Journal: Blood
Blood (2025) 146 (Supplement 1): 1940.
https://doi.org/10.1182/blood-2025-1940
Published: 2025
Journal Articles

One-year follow-up of CD19/BCMA dual-targeting fastcar-T GC012F (AZD0120) therapy in patients with refractory systemic lupus erythematosus

Free
Jingjing Feng, Heng Cao, Mingming Zhang, Xintong Feng, Shan Fu, Guoqing Wei, Ruimin Hong, Lianjun Shen, Jin Lin, Zhihong Liu, Jia Liu, Yongxian Hu, He Huang
Journal: Blood
Blood (2025) 146 (Supplement 1): 2384.
https://doi.org/10.1182/blood-2025-2384
Published: 2025
Journal Articles

Long-Term Follow-up of Sequential Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Acute Lymphoblastic Leukemia Patients Achieving MRD-Negative CR after CAR-T Therapy

Free
Tingting Yang, Yetian Dong, Jimin Shi, Mingming Zhang, Jingjing Feng, Shan Fu, Pingnan Xiao, Ruimin Hong, Huijun Xu, Yi Luo, Yanmin Zhao, Jian Yu, Xiaoyu Lai, Huarui Fu, Yishan Ye, Jiazhen Cui, Simao Huang, Guoqing Wei, Alex H. Chang, He Huang, Yongxian Hu
Journal: Blood
Blood (2024) 144 (Supplement 1): 7420.
https://doi.org/10.1182/blood-2024-209418
Published: 2024
Journal Articles

1‰ Regular Dose of Metabolically Armored CD19 CAR-T Cells Induces Robust in vivo Expansion and Complete Remission in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Patients

Free
Yongxian Hu, Mingming Zhang, Shan Fu, Ruimin Hong, Jiazhen Cui, Simao Huang, Min Gao, Daojun Bai, Jingjing Ren, Xingbing Wang, Yugang Guo, Li Tang, He Huang
Journal: Blood
Blood (2024) 144 (Supplement 1): 2074.
https://doi.org/10.1182/blood-2024-207694
Published: 2024
Journal Articles

Sequential CD19 and CD22 CAR-T Therapy in Relapsed/Refractory Acute Lymphoblastic Leukemia

Free
Tingting Yang, Yetian Dong, Mingming Zhang, Jingjing Feng, Shan Fu, Pingnan Xiao, Ruimin Hong, Huijun Xu, Jiazhen Cui, Simao Huang, Guoqing Wei, Alex H. Chang, He Huang, Yongxian Hu
Journal: Blood
Blood (2024) 144 (Supplement 1): 2818.
https://doi.org/10.1182/blood-2024-210124
Published: 2024
Journal Articles

Rituximab, Lenalidomide, and Zanubrutinib (ZR 2) with Sequential CAR-T Cell As First-Line Therapy for High-Risk Large B Cell Lymphoma

Free
Mingming Zhang, Yongxian Hu, Guoqing Wei, Shan Fu, Jingjing Feng, Ruimin Hong, Alex H. Chang, He Huang
Journal: Blood
Blood (2024) 144 (Supplement 1): 91.
https://doi.org/10.1182/blood-2024-210462
Published: 2024
Journal Articles

APRIL CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma: A Phase I Clinical Trial

Free
Wenxiao Li, Yongxian Hu, Mingming Zhang, Xinyi Lai, Mengyu Zhao, Shan Fu, Ruimin Hong, Alex H. Chang, He Huang
Journal: Blood
Blood (2024) 144 (Supplement 1): 7229.
https://doi.org/10.1182/blood-2024-209660
Published: 2024
Journal Articles

A Novel Generation of Anti-CD7 Universal CAR-T Therapy for Patients with Relapsed or Refractory CD7 Positive T-ALL/Lbl: A Phase I Clinical Trial

Free
Yongxian Hu, Yali Zhou, Mingming Zhang, Shan Fu, Yong Yu, Ming Gao, Ruimin Hong, Houli Zhao, Lu Han, Jiangtao Ren, He Huang
Journal: Blood
Blood (2024) 144 (Supplement 1): 921.
https://doi.org/10.1182/blood-2024-207322
Published: 2024
Journal Articles

Neither Conditioning Chemotherapy Nor GvHD-Prophylaxis: CD7 CAR-T Treatment Bridging to Haplo-HSCT

Free
Yongxian Hu, Mingming Zhang, Tingting Yang, Ruirui Jing, Houli Zhao, Rongrong Chen, Tianning Gu, Pingnan Xiao, Ruimin Hong, Jingjing Feng, Shan Fu, Delin Kong, Huijun Xu, Jiazhen Cui, Simao Huang, Bin Liang, Guoqing Wei, Xiaolin Yuan, Qu Cui, Jiangtao Ren, Alex H. Chang, Dongrui Wang, He Huang
Journal: Blood
Blood (2023) 142 (Supplement 1): 1039.
https://doi.org/10.1182/blood-2023-185697
Published: 2023
Journal Articles

Dasatinib and CAR-T Cell Therapy for Newly Diagnosed Ph-Positive Acute Lymphoblastic Leukemia in Adults

Free
Mingming Zhang, Yongxian Hu, Guoqing Wei, Shan Fu, Jingjing Feng, Ruimin Hong, Alex H. Chang, He Huang
Journal: Blood
Blood (2023) 142 (Supplement 1): 891.
https://doi.org/10.1182/blood-2023-186225
Published: 2023
Journal Articles

Genomic and Transcriptomic Profiling Reveal the Mechanism and Risk Factors of CD19-Negative Relapse after CAR-T Cell Therapy

Free
Ruimin Hong, Linghui Zhou, Ye Meng, Mingming Zhang, Houli Zhao, Jiazhen Cui, Simao Huang, Yongxian Hu, He Huang
Journal: Blood
Blood (2022) 140 (Supplement 1): 6354–6355.
https://doi.org/10.1182/blood-2022-164955
Published: 2022
Journal Articles

Clinical Characterization and Risk Factors Associated with Cytokine Release Syndrome Induced By COVID-19 and Chimeric Antigen Receptor T-Cell Therapy

Free
Ruimin Hong, Houli Zhao, MD, Yiyun Wang, Yu Chen, Hongliu Cai, Yongxian Hu, MD, Guoqing Wei, MD, He Huang, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 35–36.
https://doi.org/10.1182/blood-2020-139007
Published: 2020